Pulmonary nocardiosis

Changed by Yuranga Weerakkody, 23 Nov 2020

Updates to Article Attributes

Body was changed:

Pulmonary nocardiosis is an infrequent but severe opportunistic infection typified by necrotic or cavitatory consolidation in an immunocompromised patient. It is caused by Nocardia spp.

Epidemiology

The condition is rare in general. Immunocompromised patients, particularly those with impaired cell-mediated immunity related to AIDS and transplantation are particularly prone.

Incidence rates however may have increased probably due to a combination improved laboratory detection techniques as well as greater number of individuals with impaired cellular immunity 2

Pathology

Nocardia species are Gram-positive, branching, fillamentous aerobic bacteria. 

It is most commonly caused by Nocardia asteroides which is an aerobic gram positive weakly acid-fast bacterium distributed worldwide in soils. Other less common strains include Nocardia farcinica and Nocardia otitidiscaviarum 3. It is usually acquired by direct inhalation of contaminated soil.

Distribution

There may be an increased upper zonal predilection 1.

Risk factors 

Most patients have underlying respiratory disorders ranging chronic obstructive airway disease (COAD), asthma and bronchiectasis to less common ones such as previous tuberculosis and cystic fibrosis 11.

Radiographic features

Due to high rate of diffuse hematogenous spread, suspected cases of pulmonary nocardiosis should have a brain MRI to exclude cerebral abscess formation. Other organs such as liver, adrenal, skin, and soft tissues can also be involved.

Plain radiograph / CT

There are several reported radiographic patterns which include:

Other accompanying features which are non-specific on their own include:

Those with immunodeficiency may show more cavitating lesions and multiple nodules 6.

The temporal progression of radiographic abnormalities tends to be slow.

Different spread patterns have given varying features:

  • endobronchial spread
    • can occur with cavitation 
    • characterised by the presence of small centrilobular nodules, often associated with bronchial wall thickening and endobronchial debris 
  • disseminated pulmonary nocardiosis
    • consists of numerous nodules of various sizes

Treatment and prognosis

The usual treatment of choice includes sulphonamides and more recently TMP-SMX (cotrimoxazole). With certain complications, surgical drainage may be required. The prognosis can vary with those with disseminated nocardiosis having mortality rates up to 40%. Subtherapeutic levels of antibiotics can result in flare-ups while patients are on treatments. 

Differential diagnosis 

On imaging it can sometimes mimic:

  • -<p><strong>Pulmonary nocardiosis </strong>is an infrequent but severe opportunistic infection typified by necrotic or cavitatory consolidation in an immunocompromised patient. It is caused by <em>Nocardia spp</em>.</p><h4>Epidemiology</h4><p>The condition is rare in general. Immunocompromised patients, particularly those with impaired cell-mediated immunity related to AIDS and transplantation are particularly prone.</p><p>Incidence rates however may have increased probably due to a combination improved laboratory detection techniques as well as greater number of individuals with impaired cellular immunity <sup>2</sup>. </p><h4>Pathology</h4><p>It is most commonly caused by <em>Nocardia asteroides</em> which is an aerobic gram positive weakly acid-fast bacterium distributed worldwide in soils. Other less common strains include <em>Nocardia farcinica</em> and <em>Nocardia otitidiscaviarum </em><sup>3</sup>. It is usually acquired by direct inhalation of contaminated soil.</p><h5>Distribution</h5><p>There may be an increased upper zonal predilection<sup> 1</sup>.</p><h4>Radiographic features</h4><p>Due to high rate of diffuse hematogenous spread, suspected cases of pulmonary nocardiosis should have a brain MRI to exclude cerebral abscess formation. Other organs such as liver, adrenal, skin, and soft tissues can also be involved.</p><h5>Plain radiograph / CT</h5><p>There are several reported radiographic patterns which include:</p><ul>
  • +<p><strong>Pulmonary nocardiosis </strong>is an infrequent but severe opportunistic infection typified by necrotic or cavitatory consolidation in an immunocompromised patient. It is caused by <em>Nocardia spp</em>.</p><h4>Epidemiology</h4><p>The condition is rare in general. Immunocompromised patients, particularly those with impaired cell-mediated immunity related to AIDS and transplantation are particularly prone.</p><p>Incidence rates however may have increased probably due to a combination improved laboratory detection techniques as well as greater number of individuals with impaired cellular immunity <sup>2</sup>. </p><h4>Pathology</h4><p>Nocardia species are Gram-positive, branching, fillamentous aerobic bacteria. </p><p>It is most commonly caused by <em>Nocardia asteroides</em> which is an aerobic gram positive weakly acid-fast bacterium distributed worldwide in soils. Other less common strains include <em>Nocardia farcinica</em> and <em>Nocardia otitidiscaviarum </em><sup>3</sup>. It is usually acquired by direct inhalation of contaminated soil.</p><h5>Distribution</h5><p>There may be an increased upper zonal predilection<sup> 1</sup>.</p><h5>Risk factors </h5><p>Most patients have underlying respiratory disorders ranging chronic obstructive airway disease (COAD), asthma and bronchiectasis to less common ones such as previous tuberculosis and cystic fibrosis <sup>11</sup>.</p><h4>Radiographic features</h4><p>Due to high rate of diffuse hematogenous spread, suspected cases of pulmonary nocardiosis should have a brain MRI to exclude cerebral abscess formation. Other organs such as liver, adrenal, skin, and soft tissues can also be involved.</p><h5>Plain radiograph / CT</h5><p>There are several reported radiographic patterns which include:</p><ul>
  • -<a href="/articles/pulmonary-cavity">lung cavitating lesions</a>: may occur in up to a 3<sup>rd </sup>patients<sup> 4</sup>
  • +<a href="/articles/pulmonary-cavities-1">lung cavitating lesions</a>: may occur in up to a 3<sup>rd </sup>patients<sup> 4</sup>

References changed:

  • 11. Hui C, Au V, Rowland K, Slavotinek J, Gordon D. Pulmonary Nocardiosis Re-Visited: Experience of 35 Patients at Diagnosis. Respir Med. 2003;97(6):709-17. <a href="https://doi.org/10.1053/rmed.2003.1505">doi:10.1053/rmed.2003.1505</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/12814159">Pubmed</a>
  • 12. Rivière F, Billhot M, Soler C, Vaylet F, Margery J. Pulmonary Nocardiosis in Immunocompetent Patients: Can COPD Be the Only Risk Factor? Eur Respir Rev. 2011;20(121):210-2. <a href="https://doi.org/10.1183/09059180.00002211">doi:10.1183/09059180.00002211</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/21881150">Pubmed</a>
  • 13. Aggarwal D, Garg K, Chander J, Saini V, Janmeja A. Pulmonary Nocardiosis Revisited: A Case Series. Lung India. 2015;32(2):165-8. <a href="https://doi.org/10.4103/0970-2113.152638">doi:10.4103/0970-2113.152638</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/25814804">Pubmed</a>

ADVERTISEMENT: Supporters see fewer/no ads